MR3 Medical, LLC
Records under this name other than the patents MR3 Medical, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,446,247 | System and Method for Stimulating the Heart Using Sub-Threshold Biphasic Stimulation Formerly held In force · High confidence | In force | High confidence | |
| US 9,610,446 | System and Method for Stimulating the Heart Using Sub-Threshold Biphasic Stimulation Held by another company In force · Low confidence | In force | Low confidence | |
| US 9,186,516 | System for Stimulating the Heart via Storage of Multi-Waveforms in a Cardiac Stimulation Device Formerly held In force · High confidence | In force | High confidence | |
| US 9,566,446 | System and Method for Stimulating the Heart via Storage of Multi-Waveforms in a Cardiac Stimulation Device Held by another company In force · Low confidence | In force | Low confidence | |
| US 9,616,236 | System and Method for Stimulating the Heart via the Vagus Nerve Formerly held In force · High confidence | In force | High confidence | |
| US 10,940,318 | Method and Apparatus for Electrical Current Therapy of Biological Tissue Formerly held In force · High confidence | In force | High confidence | |
| US 9,610,247 | Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease Formerly held Lapsed on the fee record Ended Apr 4, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 4, 2025 | USPTO record |
| US 8,290,585 | Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool Term ended Term ended Dec 10, 2021 · USPTO record | Term ended | Term ended Dec 10, 2021 | USPTO record |
| US 6,332,096 | Augmentation of electrical conduction and contractility by biphasic cardiac pacing Term ended Term ended Feb 16, 2020 · USPTO record | Term ended | Term ended Feb 16, 2020 | USPTO record |
| US 6,411,845 | System for multiple site biphasic stimulation to revert ventricular arrhythmias Term ended Ended no later than Mar 4, 2019 · USPTO record | Term ended | Ended no later than Mar 4, 2019 | USPTO record |